Read our insights and commentary about industry news and innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.
Showing 5 of 30 posts
May 18, 2020 | Research posters
A research poster identifying instances where manufacturer HEOR data and/or pharmacoeconomic models either influenced positive changes, or had limited tangible impact on resultant US payer coverage decisions.
May 13, 2020 | Podcasts
Andrew Gould asks our US payer panel for their expert perspectives surrounding the management of gene therapies, both now and in the future.
May 7, 2020 | Podcasts
Patent management is the hot topic of this episode. The focus is on AMARIN’s leading product, VASCEPA, a drug made up of natural derivatives such as fish oil and was approved by the FDA in December 2019.
May 5, 2020 | Podcasts
Andrew Gould asks our US payer panel for their expert perspectives surrounding pricing for uncertain future indications.
March 24, 2020 | Blog
The tumor-agnostic space is incredibly exciting and an area that is likely to be explored further. CBPartners’ blog post addresses the current precision medicine landscape, touching upon challenges, as well as key commercial considerations.